Summit Financial Group’s Edwards Lifesciences EW Stock Holding History

Summit Financial Group’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$1.56M	Hold	16,333	–	–	0.55%	51
2023 Q4	$1.25M	Sell	16,333 -3,480	-18%	-$242K	0.48%	61
2023 Q3	$1.37M	Buy	19,813 +70	+0.4%	+$5.63K	0.58%	49
2023 Q2	$1.86M	Hold	19,743	–	–	0.72%	39
2023 Q1	$1.63M	Hold	19,743	–	–	0.62%	48
2022 Q4	$1.47M	Hold	19,743	–	–	0.58%	47
2022 Q3	$1.63M	Buy	19,743 +63	+0.3%	+$6.06K	0.68%	41
2022 Q2	$1.87M	Hold	19,680	–	–	0.72%	42
2022 Q1	$2.32M	Hold	19,680	–	–	0.78%	36
2021 Q4	$2.55M	Hold	19,680	–	–	0.83%	37
2021 Q3	$2.23M	Hold	19,680	–	–	0.81%	36
2021 Q2	$2.04M	Hold	19,680	–	–	0.76%	35
2021 Q1	$1.65M	Hold	19,680	–	–	0.68%	41
2020 Q4	$1.79M	Hold	19,680	–	–	0.79%	39
2020 Q3	$1.57M	Hold	19,680	–	–	0.78%	35
2020 Q2	$1.36M	Hold	19,680	–	–	0.71%	40
2020 Q1	$1.24M	Hold	19,680	–	–	0.74%	38
2019 Q4	$1.53M	Hold	19,680	–	–	0.73%	40
2019 Q3	$1.44M	Hold	19,680	–	–	0.73%	38
2019 Q2	$1.21M	Hold	19,680	–	–	0.55%	49
2019 Q1	$1.25M	Hold	19,680	–	–	0.98%	31
2018 Q4	$1M	Hold	19,680	–	–	0.85%	39
2018 Q3	$1.14M	Hold	19,680	–	–	0.85%	40
2018 Q2	$955K	Hold	19,680	–	–	0.74%	49
2018 Q1	$915K	Hold	19,680	–	–	0.72%	52
2017 Q4	$739K	Hold	19,680	–	–	0.6%	55
2017 Q3	$717K	Buy	+19,680	New	+$751K	0.6%	54

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Summit Financial Group's EW Position: Q1 2024 in Review

Summit Financial Group held its Edwards Lifesciences (EW) position steady in Q1 2024 at 16,333 shares worth $1.56M. The position accounts for 0.55% of the portfolio, ranked #51.

Summit Financial Group first reported a position in EW in Q3 2017 and has held it in 27 quarters since. The position peaked at $2.55M in Q4 2021. 1,279 funds tracked by Wall St. Rank hold EW as of Q1 2024.

Summit Financial Group held 16,333 shares of Edwards Lifesciences worth $1.56M as of Q1 2024.
Summit Financial Group left its Edwards Lifesciences share count unchanged in Q1 2024.
Edwards Lifesciences made up 0.55% of Summit Financial Group's portfolio in Q1 2024, its #51 holding.
Summit Financial Group first reported a position in Edwards Lifesciences in Q3 2017 and has held it in 27 quarters since.
Summit Financial Group's Edwards Lifesciences position peaked at $2.55M in Q4 2021.
1,279 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2024.

Based on Summit Financial Group's 13F filing for Q1 2024, filed 5 Apr 2024.